drug class of tirzepatide At a glance factsheet: for management type 2 diabetes Tirzepatide for Medical Weight Loss

Wegovy (semaglutide) is FDA-approved to: Help with long-term weight management in adults and adolescents 12 years and older with obesity, alongside diet and exercise

Metabolic reprogramming has been a focal point in the study of numerous diseases in recent years, with well-established theories, particularly in oncology

A study published in the journal Diabetes, Obesity and Metabolism found that patients on once-weekly semaglutide experienced significant decreases in serum B12 levels alongside reductions in zinc and albumin

Extracorporeal shock wave therapy effectively prevented diabetic neuropathy

Diet quality matters more than calorie counting on semaglutide

February 2, 2026: Over 100 New Ozempic Lawsuits Filed Dozens of new lawsuits involving Ozempic and drugs like it have been filed in just the past few weeks